Blog
Insights & Research
Technical deep-dives, product updates, and perspectives on the future of AI in life sciences.
NutraFold v3.0: Sub-Angstrom Protein Structure Prediction at Scale
Our latest protein structure prediction model achieves 0.92 GDT-TS on CASP15 targets, with 3x faster inference on NVIDIA H100 clusters.
Federated Bioinformatics: Running Multi-Site Genomic Studies Without Moving Patient Data
How our federated compute architecture enables HIPAA-compliant collaborative research across institutional boundaries.
From Variant to Verdict: Automating ACMG Classification with Deep Learning
NutraGenome's new variant classifier reduces manual review time by 87% while matching expert pathologist concordance rates.
Why We Chose Equivariant Graph Neural Networks for Molecular Generation
A technical deep-dive into the architecture decisions behind NutraDiscover's generative chemistry engine.
Nutracie Partners with Three Top-20 Pharma Companies for Oncology Discovery
Expanding our enterprise footprint with multi-year AI drug discovery collaborations in immuno-oncology and solid tumors.
Multi-Omics Integration Reveals Novel Biomarkers in Alzheimer's Disease
Using NutraOmics to analyze a 4,200-patient longitudinal cohort, we identified 23 previously unreported multi-modal biomarker signatures.
Benchmarking AI Drug Discovery: How Nutracie Compares to AlphaFold, DiffDock, and RFdiffusion
An honest comparison of leading AI platforms across structure prediction, molecular docking, and de novo design tasks.
SOC 2 Type II Certification: What It Means for Our Customers
Nutracie has achieved SOC 2 Type II compliance. Here's what changed in our infrastructure and what it means for your data.
Stay Updated
Get the latest research, product updates, and industry insights delivered to your inbox.